Human Xtensions Ltd - Asset Resilience Ratio

Latest as of June 2024: 29.83%

Human Xtensions Ltd (HUMX) has an Asset Resilience Ratio of 29.83% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

ILA6.13 Million
≈ $16.44K USD Cash + Short-term Investments

Total Assets

ILA20.55 Million
≈ $55.10K USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2023)

This chart shows how Human Xtensions Ltd's Asset Resilience Ratio has changed over time. Check HUMX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Human Xtensions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Human Xtensions Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ILA0.00 0%
Short-term Investments ILA6.13 Million 29.83%
Total Liquid Assets ILA6.13 Million 29.83%

Asset Resilience Insights

  • Very High Liquidity: Human Xtensions Ltd maintains exceptional liquid asset reserves at 29.83% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Human Xtensions Ltd Industry Peers by Asset Resilience Ratio

Compare Human Xtensions Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
APT Medical Inc
SHG:688617
Medical Devices 8.63%
Medacta Group SA
SW:MOVE
Medical Devices 0.86%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 34.47%

Annual Asset Resilience Ratio for Human Xtensions Ltd (2020–2023)

The table below shows the annual Asset Resilience Ratio data for Human Xtensions Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 35.53% ILA12.45 Million
≈ $33.37K
ILA35.02 Million
≈ $93.90K
-5.95pp
2022-12-31 41.49% ILA30.01 Million
≈ $80.45K
ILA72.33 Million
≈ $193.92K
+4.14pp
2021-12-31 37.35% ILA45.01 Million
≈ $120.67K
ILA120.51 Million
≈ $323.07K
+36.75pp
2020-12-31 0.60% ILA997.00K
≈ $2.67K
ILA166.34 Million
≈ $445.96K
--
pp = percentage points

About Human Xtensions Ltd

TA:HUMX Israel Medical Devices
Market Cap
$2.12 Million
ILA789.30 Million ILA
Market Cap Rank
#29941 Global
#439 in Israel
Share Price
ILA29.50
Change (1 day)
+0.00%
52-Week Range
ILA29.50 - ILA29.50
All Time High
ILA3267.00
About

Human Xtensions Ltd., a medical robotics company, develops, manufactures, markets, and sells modular medical device for minimally invasive surgical operations in Israel. The company offers HandX, a handheld smart laparoscopy solution for use in laparoscopic surgeries; fenestrated grasper; monopolar hook; monopolar spatula; monopolar scissors; self-righting needle holder; and needle holder. Human … Read more